Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Metameric spinal AVM: Long-term symptomatic relief achieved by embolization of the extradural component.

Drake B, Patro S, Quateen A, Cora EA, Finitsis S, Sinclair J, Lesiuk H, Iancu D.

Interv Neuroradiol. 2019 Aug;25(4):469-473. doi: 10.1177/1591019919828135. Epub 2019 Mar 28.

PMID:
30922201
2.

Transient in-stent stenosis at mid-term angiographic follow-up in patients treated with SILK flow diverter stents: incidence, clinical significance and long-term follow-up.

Essbaiheen F, AlQahtani H, Almansoori TM, Cora EA, Patro S, Tsehmaister-Abitbul V, Drake B, Lesiuk H, Finitsis SN, Iancu D.

J Neurointerv Surg. 2019 Feb;11(2):166-170. doi: 10.1136/neurintsurg-2018-013928. Epub 2018 Sep 7.

PMID:
30194108
3.

Stent-assisted coiling of posterior inferior cerebellar artery aneurysm complicated by arterial avulsion.

Cora EA, Finitsis S, Woulfe J, Essbaiheen F, AlQahtani H, Drake B, Lesiuk H, Iancu D.

Interv Neuroradiol. 2018 Dec;24(6):650-654. doi: 10.1177/1591019918793353. Epub 2018 Aug 19.

PMID:
30124093
4.

CTA in acute stroke: short intensive training intervention is highly effective in improving radiologists' performance.

Cora EA, Ford GA, Flynn D, Gonsalves P, White P.

Clin Radiol. 2017 Oct;72(10):871-877. doi: 10.1016/j.crad.2017.04.015. Epub 2017 May 30.

PMID:
28576436
5.

Sexual dimorphism in cancer.

Clocchiatti A, Cora E, Zhang Y, Dotto GP.

Nat Rev Cancer. 2016 May;16(5):330-9. doi: 10.1038/nrc.2016.30. Epub 2016 Apr 15. Review.

6.

RNA clamping by Vasa assembles a piRNA amplifier complex on transposon transcripts.

Xiol J, Spinelli P, Laussmann MA, Homolka D, Yang Z, Cora E, Couté Y, Conn S, Kadlec J, Sachidanandam R, Kaksonen M, Cusack S, Ephrussi A, Pillai RS.

Cell. 2014 Jun 19;157(7):1698-711. doi: 10.1016/j.cell.2014.05.018. Epub 2014 Jun 5.

7.

The MID-PIWI module of Piwi proteins specifies nucleotide- and strand-biases of piRNAs.

Cora E, Pandey RR, Xiol J, Taylor J, Sachidanandam R, McCarthy AA, Pillai RS.

RNA. 2014 Jun;20(6):773-81. doi: 10.1261/rna.044701.114. Epub 2014 Apr 22.

8.

Shedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease/fibronectin/integrin axis and inhibited by cetuximab.

Wilken JA, Perez-Torres M, Nieves-Alicea R, Cora EM, Christensen TA, Baron AT, Maihle NJ.

Biochemistry. 2013 Jul 2;52(26):4531-40. doi: 10.1021/bi400437d. Epub 2013 Jun 21.

PMID:
23731208
9.

A role for Fkbp6 and the chaperone machinery in piRNA amplification and transposon silencing.

Xiol J, Cora E, Koglgruber R, Chuma S, Subramanian S, Hosokawa M, Reuter M, Yang Z, Berninger P, Palencia A, Benes V, Penninger J, Sachidanandam R, Pillai RS.

Mol Cell. 2012 Sep 28;47(6):970-9. doi: 10.1016/j.molcel.2012.07.019. Epub 2012 Aug 16.

10.

Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.

Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ.

Clin Cancer Res. 2010 Mar 15;16(6):1904-14. doi: 10.1158/1078-0432.CCR-09-2282. Epub 2010 Mar 9.

11.

Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.

Baron AT, Lafky JM, Boardman CH, Cora EM, Buenafe MC, Liu D, Rademaker A, Fishman DA, Podratz KC, Reiter JL, Maihle NJ.

Cancer Treat Res. 2009;149:189-202. doi: 10.1007/978-0-387-98094-2_9. Review. No abstract available.

PMID:
19763437
12.

Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.

Perez-Torres M, Valle BL, Maihle NJ, Negron-Vega L, Nieves-Alicea R, Cora EM.

Exp Cell Res. 2008 Oct 1;314(16):2907-18. doi: 10.1016/j.yexcr.2008.07.013. Epub 2008 Jul 25.

PMID:
18687326
13.

The kinetics of the hydrogen/deuterium exchange of epidermal growth factor receptor ligands.

Iloro I, Narváez D, Guillén N, Camacho CM, Guillén L, Cora E, Pastrana-Ríos B.

Biophys J. 2008 May 15;94(10):4041-55. doi: 10.1529/biophysj.107.125856. Epub 2008 Jan 16.

14.

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole.

Lafky JM, Baron AT, Cora EM, Hillman DW, Suman VJ, Perez EA, Ingle JN, Maihle NJ.

Cancer Res. 2005 Apr 15;65(8):3059-62.

15.

Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.

Baron AT, Cora EM, Lafky JM, Boardman CH, Buenafe MC, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):103-13.

16.

EGF/ErbB receptor family in ovarian cancer.

Maihle NJ, Baron AT, Barrette BA, Boardman CH, Christensen TA, Cora EM, Faupel-Badger JM, Greenwood T, Juneja SC, Lafky JM, Lee H, Reiter JL, Podratz KC.

Cancer Treat Res. 2002;107:247-58. Review.

PMID:
11775453
17.
18.

Induction of experimental myasthenia gravis in rhesus monkeys: a model for the study of the human disease.

Toro-Goyco E, Cora EM, Kessler MJ, Martinez-Carrion M.

P R Health Sci J. 1986 Apr;5(1):13-8.

PMID:
3797623
19.

Role of high-fat diet in tumorigenesis in C57BL/1 mice.

El-Khatib SM, Cora EM.

J Natl Cancer Inst. 1981 Feb;66(2):297-301.

PMID:
6935479

Supplemental Content

Support Center